Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific immunotherapy.

M Larché1

  • 1Imperial College School of Medicine, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK.

British Medical Bulletin
|May 22, 2001
PubMed
Summary

Allergic diseases are rising globally, becoming a leading cause of chronic illness. Current treatments focus on symptom relief, but specific allergen immunotherapy (SIT) offers a disease-modifying approach by desensitizing patients to allergens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Perspectives in allergen immunotherapy: 2017 and beyond.

Allergy·2017
Same author

Novel approaches and perspectives in allergen immunotherapy.

Allergy·2017
Same author

Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.

Allergy·2017
Same author

A case of resistant spondyloarthritis (SpA) that responded to tacrolimus and mycophenolate treatment initiated at the time of renal transplantation for unrelated renal failure.

Scandinavian journal of rheumatology·2016
Same author

Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity.

Allergy·2015

Area of Science:

  • Allergy and Immunology
  • Public Health

Background:

  • Atopic allergic diseases have seen a significant rise, becoming a major chronic health issue in industrialized nations.
  • Despite pharmaceutical efforts, progress in disease-modifying therapies remains limited, with a focus on palliative symptom treatment.

Purpose of the Study:

  • To highlight the increasing prevalence of atopic allergic diseases.
  • To discuss the limitations of current palliative treatments.
  • To introduce specific allergen immunotherapy (SIT) as a disease-modifying alternative.

Main Methods:

  • Review of current trends in atopic disease prevalence.
  • Analysis of therapeutic approaches, distinguishing between palliative and disease-modifying strategies.
  • Description of specific allergen immunotherapy (SIT) as a non-palliative treatment.

Main Results:

  • Atopic allergic diseases represent the most common cause of chronic ill health in industrialized countries.
  • Existing treatments predominantly focus on symptom palliation rather than addressing the underlying causes.
  • Specific allergen immunotherapy (SIT) is identified as the primary non-palliative, disease-modifying therapy currently employed.

Conclusions:

  • The rising incidence of allergic diseases necessitates a shift towards disease-modifying therapies.
  • Specific allergen immunotherapy (SIT) offers a promising approach to desensitize allergic individuals and modify disease progression.

Related Experiment Videos